🎉 M&A multiples are live!
Check it out!

2seventy bio Valuation Multiples

Discover revenue and EBITDA valuation multiples for 2seventy bio and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

2seventy bio Overview

About 2seventy bio

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.


Founded

2021

HQ

United States of America
Employees

274

Website

2seventybio.com

Financials

LTM Revenue $53.7M

LTM EBITDA -$72.1M

EV

$314M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

2seventy bio Financials

2seventy bio has a last 12-month revenue of $53.7M and a last 12-month EBITDA of -$72.1M.

In the most recent fiscal year, 2seventy bio achieved revenue of $100M and an EBITDA of -$206M.

2seventy bio expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See 2seventy bio valuation multiples based on analyst estimates

2seventy bio P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $100M $49.9M XXX XXX XXX
Gross Profit $41.9M $65.3M XXX XXX XXX
Gross Margin 42% 131% XXX XXX XXX
EBITDA -$206M -$84.8M XXX XXX XXX
EBITDA Margin -206% -170% XXX XXX XXX
Net Profit -$292M -$254M XXX XXX XXX
Net Margin -291% -509% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

2seventy bio Stock Performance

As of March 14, 2025, 2seventy bio's stock price is $5.

2seventy bio has current market cap of $259M, and EV of $314M.

See 2seventy bio trading valuation data

2seventy bio Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$314M $259M XXX XXX XXX XXX $-0.75

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

2seventy bio Valuation Multiples

As of March 14, 2025, 2seventy bio has market cap of $259M and EV of $314M.

2seventy bio's trades at 5.8x LTM EV/Revenue multiple, and -4.4x LTM EBITDA.

Analysts estimate 2seventy bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for 2seventy bio and 10K+ public comps

2seventy bio Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $314M XXX XXX XXX
EV/Revenue 6.3x XXX XXX XXX
EV/EBITDA -3.7x XXX XXX XXX
P/E -6.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get 2seventy bio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

2seventy bio Valuation Multiples

2seventy bio's NTM/LTM revenue growth is 30%

2seventy bio's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $1.1M for the same period.

Over next 12 months, 2seventy bio's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate 2seventy bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for 2seventy bio and other 10K+ public comps

2seventy bio Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -50% XXX XXX XXX XXX
EBITDA Margin -170% XXX XXX XXX XXX
EBITDA Growth -59% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -140% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $1.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 230% XXX XXX XXX XXX
Opex to Revenue 299% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

2seventy bio Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Genomics & Personalized Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

2seventy bio M&A and Investment Activity

2seventy bio acquired  XXX companies to date.

Last acquisition by 2seventy bio was  XXXXXXXX, XXXXX XXXXX XXXXXX . 2seventy bio acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by 2seventy bio

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About 2seventy bio

When was 2seventy bio founded? 2seventy bio was founded in 2021.
Where is 2seventy bio headquartered? 2seventy bio is headquartered in United States of America.
How many employees does 2seventy bio have? As of today, 2seventy bio has 274 employees.
Who is the CEO of 2seventy bio? 2seventy bio's CEO is Mr. William D. Baird, III.
Is 2seventy bio publicy listed? Yes, 2seventy bio is a public company listed on NAS.
What is the stock symbol of 2seventy bio? 2seventy bio trades under TSVT ticker.
When did 2seventy bio go public? 2seventy bio went public in 2021.
Who are competitors of 2seventy bio? Similar companies to 2seventy bio include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of 2seventy bio? 2seventy bio's current market cap is $259M
What is the current revenue of 2seventy bio? 2seventy bio's last 12-month revenue is $53.7M.
What is the current EBITDA of 2seventy bio? 2seventy bio's last 12-month EBITDA is -$72.1M.
What is the current EV/Revenue multiple of 2seventy bio? Current revenue multiple of 2seventy bio is 5.8x.
What is the current EV/EBITDA multiple of 2seventy bio? Current EBITDA multiple of 2seventy bio is -4.4x.
What is the current revenue growth of 2seventy bio? 2seventy bio revenue growth between 2023 and 2024 was -50%.
Is 2seventy bio profitable? Yes, 2seventy bio is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.